Clinical Trials Congress
|Event Date/Time: Feb 13, 2006||End Date/Time: Feb 15, 2006|
During our research with over 200 of your industry peers, we found that the most critical concern for clinical
executives actively running and managing trials is process optimization: How can you fight through budgetary
constraints and decreasing timelines and get new products to market?
As a result, the 2006 event is completely updated and redesigned to provide solutions to these
Now in its 4th year, the Clinical Trial Congress (CTC) hosts an additional full day pre-event symposium, 4 new
workshops, 12 featured keynotes- including 3 cross-industry speakers, 3 new tracks, 50% more panel
discussions, nearly double the amount of speakers, and increased opportunities to network at our expanded
exhibit hall. Additionally, CTC 2006 features more case study presentations, where you can evaluate tips and
tools for improvement actively being implemented at Pfizer, Genzyme, Novartis, Johnson & Johnson, Genentech,
Bristol-Myers Squibb, Serono, Wyeth, Allergan, and Eli Lilly & Company.